Category Archives: Illinois Stem Cells

Scientists have created paper-like biomaterials from organs such as the ovaries, uterus, heart, liver and muscle that are thin and flexible enough to fold into origami birds and other structures.

These new "tissue paper" materials retain the cellular properties of the organ, so they could help the body regenerate the relevant organ tissue to aid healing of wounds, scientists said.

"Because it has components that are found in the actual tissue in the organs, the cells will recognize it once it's implanted," study co-author Ramille Shah, assistant professor of materials science and engineering at Northwestern University in Evanston, Illinois, said of the tissue paper in a video statement. [11 Body Parts Grown in the Lab]

An accidental ink spill sparked the invention of these new materials. Lead study author Adam Jakus, formerly a materials engineer at Northwestern University, had created an ink made of an ovary for use in a 3D printer. When he went to wipe up the spill, the ovary ink had already formed a dry sheet.

"When I tried to pick it up, it felt strong," Jakus said in a statement. "The light bulb went on in my head. I could do this with other organs."

So, Jakus and his colleagues took a pig or cow organ and used detergents to strip it of its cells. This left behind the extracellular matrix of the organ the scaffold of proteins that helps give an organ its structure.

The scientists then freeze-dried this organ material, ground it into a powder and mixed it with a solvent to create an ink. When films of this ink were dried, they became flat sheets of paper-like materials.

Each thin, flexible sheet of tissue paper felt and behaved much like standard office paper, Jakus said. He could even fold these sheets into an origami bird, he said.

"They're easy to store, fold, roll, suture and cut, like paper," Jakus told Live Science. "Their flat, flexible nature is important if doctors want to shape and manipulate them in surgical situations."

Each sheet of tissue paper contains residual biological molecules and protein structures from its source organs. In experiments, this tissue paper could support the growth of adult human stem cells.

The researchers suggested their new materials could stimulate cells to behave in potentially therapeutic ways. For instance, tissue paper made of muscle could help foster the growth of muscle cells.

"A lot of muscles in the face are flat and thin, and perhaps muscle tissue paper can help foster the growth of muscle cells for people who've experienced traumatic injuries, or children born with congenital defects," Jakus said.

If a kidney or a uterus is nicked by an injury or during surgery, "those organs can bleed a lot very quickly," Jakus said. "Tissue paper could act like an internal bandage for such cuts."

In addition, in experiments, ovarian tissue paper seeded with ovarian cells could produce hormones linked to puberty and fertility. Such implants could help restore normal hormone function in female cancer patients, who often lose their hormone function due to chemotherapy and radiation, said study co-author Teresa Woodruff, a reproductive scientist at Northwestern University.

"It is really amazing that meat and animal byproducts like a kidney, liver, heart and uterus can be transformed into paper-like biomaterials that can potentially regenerate and restore function to tissues and organs," Jakus said in the statement. "I'll never look at a steak or pork tenderloin the same way again."

Future research should explore if these new materials are safe and effective for use in the human body, Jakus said. In addition, the scientists are investigating making 3D objects from their organ inks using 3D printers, he said.

Jakus is now chief technology officer and co-founder of the startup company Dimension Inx, which will develop, produce and sell 3D-printable materials primarily for medical applications. These new inks will be licensed to Dimension Inx.

The scientists detailed their findings today (Aug. 7) in the journal Advanced Functional Materials.

Original article on Live Science.

Read the original post:
Origami Organs: This 'Tissue Paper' Could Help Regenerate a Heart or Uterus - Live Science

Nina Martyris is a literature-focused freelancer. Her writing has appeared in NewYorker.com, The Paris Review Daily, The Guardian, NPR and elsewhere.

Sixteen years ago, life seemed perfect for drama teacher Heather Harpham when she fell in love with Brian Morton, an award-winning novelist equipped with a "sly, sly humor." Sure, they were a study in opposites he was a disciplined, "diffident, sexy, Jewish intellectual," she a California free spirit; he ate broccoli with brown rice and garlic sauce for dinner every night, she strayed toward salty snacks and ice cream; her apartment had big, colorful posters, his had black-and-white postcards. But they were young, in love, and living in New York, and these differences only proved to be thrillingly attractive.

One difference, though, was insuperable: She wanted kids, he didn't. Neither made any secret of where they stood on the issue.

When Harpham learned she was pregnant, they broke up, and she went back to her mother's studio in California to have the baby. Lonely and furious, she was nevertheless determined to bring up her child "one-handed." Hours after the birth of her daughter, however, came a devastating diagnosis: The baby's bone marrow couldn't make red blood cells. She would require an immediate blood transfusion and frequent ones thereafter four in the first three months as it turned out to stay alive.

In her new memoir, Happiness: The Crooked Little Road to Semi-Ever After, Harpham relives the heartbreak, hope, and terror she experienced as she watched her infant daughter cross the abyss of a life-threatening disease. Into this tension-torqued story of sickness and health, she works in the fraught tale of her own evolving relationship with Morton, loading the memoir with an added intensity.

Acutely aware that her little girl, Gracie, is a victim of bad blood in more ways than one bad blood between her parents and her own malfunctioning red blood cells Harpham is a tight coil of fear and anger. Her mother, stepbrothers, and friends in California form a protective cordon around her and the baby, but their loyalty only serves to throw Morton's absence into high relief. Four months after Gracie's birth, Morton, who has called every night and been worried sick long-distance, asks if he can see his daughter. He arrives, and quite naturally, finds her irresistible.

Harpham is no longer "one-handed," but her anger doesn't dissolve overnight it's just that saving Gracie becomes the focus of her parents' world. The transfusions stabilize her, but the odds of her living past 30 are not high. There is one solution: A stem-cell transplant from a donor who is a close match. A sibling would be the answer. It would mean having another child. But what are the chances of a sibling being a perfect match? Even if there's a match, what are the chances of the transplant being successful? Failure would be fatal. Should they go ahead? It's an agonizing decision only Gracie's parents can make.

In sharp and vivid prose, Harpham tunnels through the harrowing months ahead filled with hospitals, needles, and ICUs. While the book could have benefitted from some pruning, what keeps the reader reading is the writing. Apart from the long, twee title, Harpham's language is crisp, tersely evocative (the baby freshly conceived inside her is a "grain of rice with a heartbeat"), and most bracingly for a book whose currency is pain, funny. Harpham admires Morton's sly humor, but she, too, has a gift for comedy that glints through at dour moments. It's hard not to smile, albeit with a catch in your throat, when she says her unsmiling newborn, "barely past blob status," looks "alarmingly like Alfred Hitchcock" and emits high-pitched squeaks like "a small wind instrument" and who, after a few hours out of her mother's womb, begins "to smell less like apples and more like an element, tin or iron."

Iron, of course, is the elixir the baby needs to survive, and Harpham's humor has an aching edge to it. It provides the gritty foil to lighter moments such as the hospital scene when Gracie first sets eyes on Gabriel, whose stem cells, if they turn out to match hers, could save her life. She doesn't know any of this, as she's not even two. Asked what she thinks of her brother, she peers into his face, strokes his hand, and announces: "Soft boy."

"My mom cried," writes Harpham. "Brian cried. I cried. Gabriel slept. Gracie looked at us all with baffled amusement what were we so worked up about?"

A heartfelt exploration of mortality and life, this memoir also explores the complex pulls and pushes of human relationships, and the deep debt we owe to family, friends, and modern medicine. At heart, it is a sobering mediation on the lasting impermanence of its titular emotion, happiness.

Read the rest here:
'Happiness' Explores The Complex Push And Pull Of Human Relationships - NPR Illinois | 91.9 UIS

July 31, 2017 - By Linda Rogers

Investors sentiment decreased to 0.3 in Q4 2016. Its down 0.37, from 0.67 in 2016Q3. It is negative, as 16 investors sold Neuralstem, Inc. shares while 11 reduced holdings. 2 funds opened positions while 6 raised stakes. 6.88 million shares or 44.05% less from 12.30 million shares in 2016Q3 were reported.Sabby Mgmt Limited Liability Com reported 229,521 shares. The Illinois-based Blair William Il has invested 0% in Neuralstem, Inc. (NASDAQ:CUR). Natl Bank Of America Corp De, a North Carolina-based fund reported 8,400 shares. Natl Asset Mngmt owns 167,500 shares or 0.01% of their US portfolio. Vanguard accumulated 0% or 3.09 million shares. 1.03M were accumulated by Geode Capital Limited Liability Corp. Guggenheim Ltd Liability Company, Illinois-based fund reported 51,217 shares. First Heartland Consultants Incorporated has invested 0% in Neuralstem, Inc. (NASDAQ:CUR). Cambridge stated it has 0% in Neuralstem, Inc. (NASDAQ:CUR). 141,463 were accumulated by Northern Tru. Royal Bank Of Canada stated it has 7,080 shares. Fifth Third Fincl Bank has invested 0% of its portfolio in Neuralstem, Inc. (NASDAQ:CUR). Fcg Advsrs Limited Liability Company invested in 0% or 21,000 shares. Janney Montgomery Scott reported 0% of its portfolio in Neuralstem, Inc. (NASDAQ:CUR). Blackrock Advsr Limited Liability holds 0% of its portfolio in Neuralstem, Inc. (NASDAQ:CUR) for 17,361 shares.

Since February 24, 2017, it had 3 insider buys, and 0 selling transactions for $70,004 activity. On Friday, February 24 the insider Daly Richard J bought $10,001. LLOYD JONES JONATHAN BRIAN bought $30,003 worth of Neuralstem, Inc. (NASDAQ:CUR) on Friday, March 24.

The stock of Neuralstem, Inc. (NASDAQ:CUR) hit a new 52-week low and has $1.50 target or 3.00 % below todays $1.55 share price. The 5 months bearish chart indicates high risk for the $18.62M company. The 1-year low was reported on Jul, 31 by Barchart.com. If the $1.50 price target is reached, the company will be worth $558,600 less.The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 6.63% or $0.11 on July 31, reaching $1.55. About 591,531 shares traded or 84.21% up from the average. Neuralstem, Inc. (NASDAQ:CUR) has risen 3.35% since July 31, 2016 and is uptrending. It has underperformed by 13.35% the S&P500.

More news for Neuralstem, Inc. (NASDAQ:CUR) were recently published by: Marketwatch.com, which released: UPDATE: Neuralstem stock plummets 61% on news of mid-stage clinical trial miss on July 25, 2017. Nasdaq.coms article titled: Mid-Day Market Update: ShoreTel Gains On Acquisition News; Neuralstem Shares and published on July 27, 2017 is yet another important article.

Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $18.62 million. The Firm is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. It currently has negative earnings. The Firm has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Original post:
What's Propelling Neuralstem, Inc. (CUR) to Reach 52 Week Low? - WeeklyHub

EDWARDSVILLE Explorers, expert observers and super sleuths are energizing Southern Illinois University Edwardsvilles campus during Odyssey Science Camp being held July 17-28.

Organized by the SIUE Center for STEM Research, Education and Outreach, more than 110 students, grades 2-9, are engaging in a variety of interactive activities aimed at fostering an appreciation for science, technology, engineering and mathematics (STEM).

At Odyssey Science Camp, were inspiring future scientists, investigators, mathematicians, engineers and more by introducing them to STEM concepts through activity-based instruction, said Dawn Olive, with the SIUE STEM Center. We offer students opportunities to work in a laboratory and conduct hands-on experiments that are not always possible in schools.

Camp activities range from introducing scientific principles, building math skills, conducting simple crime science investigations and constructing a Lego robot. New this year, campers are exploring renewable energy sources.

Renewable energy is an important topic, so we thought it would be valuable for students to learn more about wind turbines, solar cells, hydroelectric turbines and hydrogen-powered vehicles through hands-on activities, said instructor Ron Mayhew.

Students, grades 7-8, analyzed the angle of wind turbines blades and learned how that affects revolutions per minute (RPM). They also experimented with solar cars by testing the distance the cars traveled in relation to the amount of time they charged and weather conditions, such as cloud cover.

Ive been coming to camp for years, said Allyson Lunsford, of Glen Carbon. I like science, because there are always more answers to explore and different topics to learn. I thought I knew all about renewable energy before camp, but this class has taught me a lot more.

This is my first year at Odyssey Science Camp, and I love it, added Tyler Lintker, of Edwardsville. When I saw that I would get to be in the renewable energy course this summer, I thought it would be the perfect fit.

Not only is Odyssey Science Camp comprised of experienced area teachers, it is also supported by SIUE students who are participating in the Robert J. Noyce Scholarship Science and Math Grants, funded by the National Science Foundation, which provide summer scholarships for qualified STEM students interested in teaching. The SIUE summer scholars find it exciting to inspire younger STEM-motivated learners.

I want to be a science teacher, because I enjoy kids and one of my strengths is helping others learn, said Jenna Sanders, a rising junior majoring in biological sciences at SIUE. This extra teaching experience is integral for my growth as a future teacher. Also, this is an important age range for keeping kids involved in STEM, because their minds are shaping.

Its been great to see what the kids are interested in and help lead activities that engage them in those areas, added Dalia Hassan, a sophomore chemistry major at SIUE. These are smart kids. Im excited that theyre our future!

For more information on the SIUE STEM Centers Odyssey Science Camp, visit siue.edu/summer/camps/odyssey-science-camp.

Allyson Lunsford, Qiong Domingue and Montgomery Hubler adjust the blade angles on a wind turbine during their renewable energy course.

See the rest here:
The Telegraph | SIUE Odyssey Science Camp engages area ... - Alton Telegraph

Health care. Unless you live in a cave without wifi, you've heard the familiar rumblings of our elected officials holding the fate of every American citizen in their hands while they decide what to do about it. I have a lot of thoughts about how something that impacts so many could be determined by thirteen white men in DC (and, yes, the fact that they are white men is relevant and worth noting), a lot of thoughts, but instead, I will share the story of my daughter being a Medicaid recipient.

Once upon a time, March 23, 2007 to be precise, my not quite two year old daughter Donna was diagnosed with a brain tumor. My husband and I both worked at the time, he at a job he had been at for five years and me at a job I had been at for nine years. I was thrilled to be able to transition to part-time hours after my girl was born and felt lucky most every day. Our family benefited from generous employer provided benefits.

I needed to exit my position when it became clear that the care our girl would require would prevent me from being available to work on any consistent basis. After diagnosis and her initial surgery to remove the tumor, our girl relapsed six weeks later. That resulted in another hastily scheduled brain surgery and the need for chemotherapy that would require hospital stays of 3-7 days twice monthy for an unspecified time. We needed to tighten our belts a bit, but we could and did.

Many cancers are understood adequately enough to follow a treatment protocol. If you have a boy with leukemia, you know that he will be in treatment for three to three and a half years. A dear friend who cares for a daughter with a brain tumor learned a couple of years post diagnosis that her girl would need to receive a new regimen of chemotherapy once a week for 52 weeks. Now, none of these protocol are set in stone, as at any time, something could happen that would require changes -- the cancer could return, metasticize, infection could set in, the chemo could stop working.

For the cancer my daughter had, papillary meningioma, no such treatment protocol exists. Not enough research has been done to understand it -- actually, nothing more than anecdotal studies have been published about this particular type of brain cancer and no research or funds are devoted to better understanding it. As the docs explained, that was both good and bad. Bad because, well, there was no plan, and good because, well, they could try what they had and hope for the best, as nothing out there suggested it would not work. Donna's doctors chose hope and we did, too.

Initially, Donna's cancer responded to treatment incredibly well. Lesions in her lungs were erased (Donna's cancer had metasticized) and there was no sign of any returning tumor growth in her brain. The joy and relief we felt compensated for the days of suffering Donna experienced using a chemo cocktail an oncologist friend described as a "sledgehammer."

Each cycle required a five day inpatient stay followed by discharge to home followed by the onset of neutropenia followed by a second monthly hospitalization for IV antibiotics to combat any chance of infection setting in and wreaking havoc. Two weeks of the month were spent inpatient, one week spent post-chemo feeling like hell, and one blessed week a month where we could enjoy relative good health and engage in things two year olds like to do -- parks, zoo, playing outside.

We did this for six months, not knowing month to month if we would keep doing it, as we never knew if it would stop working or if it would become too toxic. After six months it did. Donna's kidneys began to fail, hit particularly hard by the chemo. The treatment team advised she stop the protocol, extract healthy cells via harvest, then have a stem cell transplant (or two, depending on whether or not she survived the first, and no, I am not joking) to provide what they hoped would be the final blow to her cancer.

A stem cell transplant is to chemo what a marathon is to a 5K.

Donna during her stem cell harvest in 10/2007.

All of this happened prior to the Affordable Care Act and an Obama presidency. My husband and I, despite being grateful for the insurance we had, were running a silent tally in our heads. Each hospital stay came with a mental $CA-CHING$ echoing in our heads. Each home health visit to access her port, each surgery, each pink plastic bowl used to catch toxic vomit was adding up. It was a pressure we lived with but didn't share. The health of our girl was consuming, so we back-burnered the worry of Donna's $2 million lifetime insurance cap, but knew we were inching closer to it every day.

In a collective fog, we marched towards Donna's stem cell transplant, only to come to a screeching halt when it was denied by our insurance carrier. In December of 2007 our family was lucky enough to live in a state and in a time that insurance was mandated for children. When our employer provided insurance denied the recommended stem cell transplant and then denied our appeal, the hospital suggested we apply for Medicaid for Donna under Illinois' All Kids program. They walked our upper middle class, naive selves through the process.

Each month a little slip of paper came in the mail that allowed Donna to access her oncologist recommended treatment. It was her Medicaid slip that held the particular sequence of letters and numbers that acted as a key to her potential health and well being. It was used exclusively during the time of her stem cell transplant and recovery, as our insurer made clear nothing related to a stem cell transplant would be eligible for coverage.

Donna's single stem cell transplant cost well over $600K. We were grateful that Medicaid covered the transplant for a couple of reasons -- 1) simply because it would be paid for without us losing our home or financial stability, and 2) because that $600K+ would have taken Donna dangerously close to her $2 million lifetime insurance cap. The short period that Donna was on Medicaid acted as a reprieve to our worries about Donna maxing out her lifetime insurance cap before reaching the age of three.

I remember the day the Affordable Care Act passed and the day the Supreme Court upheld it. While it no longer impacted our girl who died before it was passed, I celebrated for the hundreds of children and families I knew who lived with pediatric cancer and its devastating impact, both emotional and financial. I celebrated that these kids lucky enough to survive their cancer could never, ever again be denied for having had the misfortune of having a pre-existing condition. I celebrated that they would be allowed to enjoy their parent's insurance coverage until age 26. I celebrated that they would be relieved of the burden of a lifetime cap. These are good, important measures for quality of life that have nothing to do with whether you vote red or blue.

While Vice President Pence extols the virtues of "personal responsibility" and Kellyanne Conway advises people to get a job with employer provided benefits rather than rely on Medicaid, too many Americans know the reality of why that approach to health care does not scratch the surface of reality. That approach deems to separate the "deserving" poor from the "undeserving" poor. That approach does not take into account the reality of average Americans living with catastrophic illness, working jobs that do not provide a living wage, let alone health benefits, or the often random nature of illness, unemployment, and falling on hard times. My upper middle class, white lady, married, respectable, employed self needed and benefited from Medicaid when it covered our daughter after our for profit insurer denied her.

We are at the cusp of moving backwards on health care in America, dangling over a proverbial cliff that will put so many fellow Americans in harm's way. Medicaid benefits vulnerable people that you know and love -- parents and grandparents in nursing homes, veterans, children, 50% of every baby born here, people living with mental illness, people living with addiction, people living with catastrophic illness not covered by their insurance. You may never have used Medicaid yourself, but you can never claim you will never need it because, well, life.

Call your senators. Today. Now. You can find their number HERE. Tell them Donna sent you.

More here:
That Time My Daughter Was On Medicaid - ChicagoNow (blog)

Sessions/Tracks

Track 1: Pediatric Cardiology & Pulmonology

In childhood a disorder which involves both the heart and lungs problems, called PediatricCardiopulmonary disease. Epicardial adipose tissue (EAT) is the visceral fat deposit around the heart and is commonly increased in obese subjects. EAT is related to Cardio Metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) in adults, but this relationship is not well known in children. (MI)Myocardial infarctionis rare in childhood and adolescence. Children usually have either an acute inflammatory condition of thecoronary arteries diseasesor an anomalous origin of the left coronary artery (LCA). Peripheral vascular diseases (PVDs) are circulation disorders that affect blood vessels outside of the heart and brain. In PVD, blood vessels are narrowed. Narrowing is usually caused byarteriosclerosis. We will be discussed more about the common problem of the baby heart asCardiomyopathy, Myocarditis, Hypoplastic Left Heart Syndrome,Hypertension, Heart Murmur,Cardiac Arrest, Arrhythmogenic Right Ventricular Dysplasia,Cyanotic Heart Disease, and Pediatric Arrhythmia as well as more about Pediatric lungs disorders as Upper Airway Abnormalities, Child Interstitial Lung Disease (child), Chronic and Recurrent Respiratory Infections, Congenital Abnormalities and Pediatrics Chronic Obstructive Lung Diseases etc.

Track 2: Neonates Heart & Lungs Diseases Pathophysiology

During the past decade, our understanding of the pathophysiology of coronary artery disease (CAD) has undergone a remarkable evolution. We review here how these advances have altered our concepts of and clinical approaches to both the chronic and acute phases of CAD. Previously considered a cholesterol storage disease, we currently view atherosclerosis as an inflammatory disorder. Aggressive management of modifiable risk factors reduces cardiovascular events and should accompany appropriate revascularization. The main evaluation factors are Cardiovascular Biology, Blood Cholesterol & Obesity, Family history, Heart Physiology and Computational Biology of Heart etc.

Childhood lungs diseases is not a disease but a group of disorders However, most lungs diseases share a common pathophysiologic feature, namely, structural remodelling of the distal airspaces, leading to impaired gas exchange. In general, this remodelling has been believed to be the sequela of persistent inflammation; however, more recently, the paradigm has shifted away from inflammation to one of tissue injury with aberrant wound healing resulting in collagenous fibrosis.

Track 3: Pediatric Cardiovascular Nurses

Cardiac nurses possess a high level of education and experience that allows them to diagnose, treat, and manage conditions that affect the complex cardiovascular system. They work to promote optimal cardiovascular health among clients through preventative measures that involve health counselling, screening, and stress tests, as well as disease prevention and management strategies. This track having some important topics to discuss as Obstetrical Nursing, New-born Nursing Care, Pediatric Cardiac Nursing, Maternal and Child Health Nursing, Cardiac Intensive Care Nursing, Advanced Nurse Practitioners, Nursing Management and many more.

Track 4: Fetal Cardiology

The heart is the first organ to develop in your unborn baby, and is the most important to his or her lifetime of health. Fetal Cardiology program works to support childs heart health, or preparing your child for life-changing treatment. The most advanced technology to monitor developing babyincluding fetal echocardiograms and fetal MRIs for evaluationwhich reduces risk while minimizing time spent in the hospital.Our conference will give you more details information about fetal cardiovascular physiology, Fetal Bradyarrhythmias & Tachyarrhythmias and many more.

Track 5: Cardiovascular Diseases

Cardiovascular Diseases are types ofheart diseaseobserved in children and adolescents.Rheumatic heart diseasesare thought to result from an autoimmune response, but the exact pathogenesis remains unclear. As many as 39% of patients with acute rheumatic fever may develop varying degrees of pancarditis with associated valve insufficiency,heart failure, pericarditis, and even death.

This track include more about the acute coronary syndromes,Congestive Heart Failure, inflammatory heart diseases, Pediatricangina pectoris, ischaemic heart diseases, rheumaticheart diseases, valvular heart diseases, peripheral artery diseases,pulmonary embolismand vascular rings.

Track 6: Congenital Heart Diseases

A congenital heart defect is an abnormality present at birth. Most heart defects are spotted during childhood, but sometimes a person may reach adulthood before discovering a heart defect. Congenital heart defects are partly preventable through rubella vaccination, the adding of iodine to salt, and the adding of folic acid to certain food products.

This session will give brief information on atrial septal defect, Cineangiography, ventricular septal defect, Coarctation of the aorta, transposition of the great arteries, tetralogy of Fallot, acquired heart diseases, aortic dissection, myocardial infarction, pleural effusion, Endocarditis, Atrial Fibrillation atherosclerosis and many more. About the sudden cardiac death (SCD) is the unexpected death caused by loss of heart function or cardiac stroke.

Track 7: Cardiac Stroke

The two most common types of stroke are ischaemic and haemorrhagic stroke: Ischaemic strokes happen when the artery that supplies blood to your brain is blocked, for example by a blood clot and haemorrhagic strokes happen when a blood vessel bursts and bleeds into your brain, damaging brain tissue and starving some of your brain cells of blood and oxygen. Without a constant blood supply, your brain cells will be damaged or die, which can affect the way your body and mind work.

Track 8: Other Heart & Lungs Diseases

Some miscellaneous cardiac diseases arecardiomegaly-an enlarged heart. But it's usually caused by high blood pressure (hypertension) or coronary artery disease.Marfan syndromeinherited genetic defect weakens connective tissues- including those in the heart. Cardio-metabolic risk refers to your chances of having diabetes, heart disease or stroke.Kawasaki diseaseis a rare childhood illness that affects the blood vessels. A rare birth defect, heterotaxy syndrome usually involves heart defects of varying types and severity.

Under this the major sub-track arecardiovascular diseasesin diabetes, cardiovascular diseases in pregnancy, sports cardiology, non-coronary myocardial disease, infectious diseases of the heart,cardio-metabolic disorder, cardio oncology cerebrovascular diseases (stroke),Cardiopulmonary Resuscitation, Kawasaki disease,Marfan syndromeand heterodoxy syndrome.

Track 9: Echocardiography & Cardiac Diagnosis

Pediatric cardiologists are trained to diagnose and treat heart problems in infants, children and young adults. Severe heart disease generally becomes evident during the first few months after birth. Some babies are blue or have very lowblood pressureshortly after birth. Other defects cause breathing difficulties, feeding problems, or poor weight gain. Pediatric cardiologists are help to diagnose theheart diseasesbased on the medical and family histories, risk factors, a physical exam, and the results from tests and procedures asEchocardiography that is very basic test to check whether heart is having any problem or not. After the diagnosis only patient risk factor will determine and treatment will start.

The various diagnosis tests are used for specially heart disease asPediatric angiocardiography, cardiac solography, electrophysiology test, heart MRI, Fetal echocardiography,Pediatric Interventional Cardiologyendothelial function evaluation, electrophysiological studies,blood pressuremonitoring and Pediatric nuclear cardiology etc. Pediatricnuclear cardiologystudies use non-invasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of aheart attack.

Track 10: Interventional Cardiology

Interventional cardiology refers to diagnostics and non-surgical treatments of the heart. Cardiac interventions are used to diagnosis and treat many types of heart disease. Stanford interventional cardiology is a world leader in percutaneous coronary revascularization, which re-establishes blood flow to the heart when its vessels have been damaged or blocked. Each year, the staffs of the Section of Invasive and Interventional Cardiology see thousands of patients with almost every kind of heart disease. Our interventionists treat people of all ages from around the world who have serious, sometimes life-threatening, cardiac conditions.

Track 11: Pediatrics Pulmonary Diagnosis

Experts are provided for the diagnosis and care of unexplained, recurrent and chronic symptoms or diseases related to the respiratory system for infants, children and adolescents. The important procedures are Bronchoscopy, Impulse Oscillometry, Pulmonary Function Testing and many more.

Track 12: Pediatric Cardiology Advance Therapies

The early medical management of Heart Failure in infancy, childhood, and adolescence is necessary to save a child life.Pharmacologic therapyrepresents the mainstay of treatment for heart failure in children. Regenerating heart tissue throughstem cell therapyis the new technique to cure theheart diseases.

Other than the use of cardiac drugs, one therapy call, stem cell therapy and most commonly medicine use to treat or prevent thecardiac diseasesare diuretics, angiotensin-converting enzyme inhibitor,beta blockers, cardiac glycosides, antiplatelet agent,inotropic therapy, statins or cholesterol reducing drugs, prostaglandins inhibitors, angiotensin receptor blockers etc. These are the main category of medicines used to treat theheart diseases. Pulmonary Medicine has a long history of providing expert care to children and adolescents with pulmonary and sleep disorders.

Track 13: Neonatal Cardiology Surgery & Transplantation

A heart transplant is a surgical procedure performed to remove the diseased heart from a patient and replace it with a healthy one from an organ donor. In order to remove the heart from the donor, two or more doctors must declare the donor brain-dead. Before a person can be put on a waiting list for aheart transplant, a doctor makes the determination that this is the best treatment option available for the person's heart failure. The most common reason is that one or both ventricles have aren't functioning properly and severe heart failure is present.Ventricular failurecan happen in many forms of congenital heart disease, but is more common in congenital defects with a single ventricle or if long-standing valve obstruction or leakage has led to irreversibleheart failure. While a heart transplant is a major operation, your chance of survival is good, with appropriate follow-up care.

Track 14: Pediatric Cardiology Critical Care

The cardiac critical care unit is staffed by a multidisciplinary team of health care providers who work collaboratively to provide high quality care for this critically ill patient population. The team includes an attending cardiologist, a pulmonary critical care intensivist, an attending physician specializing in heart failure and a cardiac fellow-in-training. The Pediatrics Cardiac Intensive Care Unit (CICU) looks after people who are seriously ill with heart or lung problems. The following below topics will discuss under this session.

Track 15: Pediatrics Pulmonary Advance Therapies

Pediatric Pulmonary therapies offer diagnosis and treatment for children and adolescents with a range of chronic lung diseases, respiratory disorders, reactive airway diseases, and sleep-related respiratory problems. The pulmonary specialists will evaluate, treat, and manage child's care using the most advanced therapies and treatments as Cardio-Respiratory Physical Therapy, Pediatric Cardiopulmonary Perfusion and Pulmonary Rehabilitation etc.

Track 16: Pediatric Heart & Lung Cancer

Heart Cancers are an abnormal growth in the heart muscle or in one of the cardiac chambers. Heart tumors, also called cardiac tumors, are extremely rare in children. Primary lung neoplasms are also rare in children, but they comprise a broad and interesting spectrum of lesions, some of which are familiar from other tissue sites, and some of which are unique to the Pediatric lung. This session mainly focus on the different type of pediatric heart and lungs cancer as Myxomas & Fibromas, Lung Carcinoma, Rhabdomyosarcoma and Angiosarcoma etc.

Track 17: Clinical Pediatric Cardiology & Pulmonology

Research in Cardiology field comprises all aspects related to the physiology and pathology of the structure and function of the heart and the cardiovascular system, including their regulation by neuronal and humoral mechanisms, cardiovascular safety pharmacology etc. To see the drug effects on heart, scientists prefer to do clinical trials on the animals. Because of long term Malnutrition also cardiac disorder will develop in body. With the international Pediatric Cardiology 2017 Meetings or events we will get to know about the new advancements coming from different research in cardiology field.

This session mainly focus on the research on cardiology filed as clinical monitoring, case studies, cardiovascular genetics, adverse drug reaction, clinical trial management system, and experimental models of cardiovascular diseases.

Track 18: Pediatric Surgeons Meeting

Pediatric Cardiology-2017 welcomes all the Pediatricians, Cardiologists, Researchers, Pulmonologists, Student Communities, Academic & Business Delegates from Medical, Health Care institutions to join this conference in Chicago, USA. The Conference provides an excellent opportunity to share, exchange knowledge and establish research collaborations and networking. Pediatric Cardiology-2017 is an initiative to bring together the diverse communities working in the field of cardiology to help millions of children fighting with heart diseases, for better treatment and medication alternatives.

3rd Annual Summit on Pediatric Cardiology & Pulmonology will be hosted at Chicago, USA during September 25-27, 2017, with the innovative themePlanning for future success to detect, prevent or treat Neonates Heart & Lung Disorders.

Pediatric Cardiology-2017 mainly focuses on spreading the awareness about challenges in this field and how to prevent the cardiac and lung diseases. We are awaiting a great scientific faculty from USA, Europe as well as other continents and expect a highly interesting scientific as well as a representative event. We organizes aconference seriesof 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access journalswhich contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about various Pediatric cardiac diseases and how to prevent the cardiac disorders .This is your best opportunity to reach the largest assemblage of participants from the entire world. At the Pediatric cardiology conferences and from the eminent people speech, you can update your knowledge about current situation of Pediatric cardiology and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, stactics, and the newest updates in Pediatric Cardiology and Pulmonology fields are hallmarks of this conference.

Target Audience:

3rd Annual Summit on Pediatric Cardiology & Pulmonology will be hosted at Chicago, Illinois, USA during September 25-27, 2017, with the innovative theme "Planning for future success to detect, prevent or treat Neonates Heart & Lung Disorders". This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent the cardiac& lungs diseases. We are awaiting a great scientific faculty from USA, Europe as well as other continents and expect a highly interesting scientific as well as a representative event.

Importance & Scope:

Pediatric Cardiologists & Pulmonologists care for patients with congenital or acquired cardiac and cardiovascular abnormalities. The scope ofPediatric Cardiologypractice is extensive. Pediatric Cardiologists & Pulmonologists evaluate and care for foetuses, neonates, infants, children, and adolescents. Special areas of clinical and academic interest include: Intensive Cardiac Care,Cardiac Catheterizationand Intervention, Electrophysiology,Heart MRI, Fetal Pediatric Cardiology, Heart Anatomy, Exercise Physiology, Preventive Pediatric Cardiology, Patent Ductus Arteriosus, Supraventricular Tachycardia,Cardiac Failure & Transplantation, Acute & Chronic Bronchitis, Pediatrics Cystic Fibrosis, Pediatrics Tuberculosis, Cardiorespiratory Disorders, Upper Airway Abnormalities, Child Interstitial Lung Disease (ChILD), Chronic and Recurrent Respiratory Infections, Congenital Abnormalities, Pediatrics Chronic Obstructive Lung Diseases and Pulmonary Hypertension.

Congenital heart disease (CHD) is the type of heart disease that a baby is born with. In reality, it is a defect, or abnormality of the heart or blood vessels near the heart, and not a disease, so many people use the term congenital heart defect. The majority of children born today with CHD will survive and with proper treatment be able to lead a normal or near-normal life. Some kinds of CHD are mild and may not be diagnosed in infancy.Heart Murmurs is also very common disorder soon after birth.

With the internationalPediatric cardiology Congress, we will expect the expert gathering from Universe so that new idea or new research will come with discussion at the conference and that will be fruitful to children suffering from cardiac & lungs diseases.

Why Chicago (Illinois)?

Chicago is the largest city in the US state of Illinois. With nearly 2.7 million residents, it is the most populous city in the Midwestern United States and the third most populous in the USA, after New York City and Los Angeles. Its metropolitan area, sometimes called "Chicago land," is the 27th most populous urban agglomeration in the world, the largest in the Great Lakes Megalopolis, and the third largest in the United States, home to an estimated 9.8 million people spread across the US states of Illinois, Wisconsin, and Indiana. Chicago is the county seat of Cook County, the second most populous county in the United States, after Los Angeles County, California.

Market analysis of Chicago, Illinois

Associations & Society Associated with Pediatric Cardiology in Chicago:

Associations & Society Associated with Pediatric Cardiology in USA:

Associations & Society Associated with Pediatric Cardiology Worldwide:

Universities Associated with Pediatric Cardiology in Chicago:

Universities Associated with Pediatric Cardiology in USA:

Universities Associated with Pediatric Cardiology Worldwide:

Hospitals Associated with Pediatric Cardiology in Chicago:

Hospitals Associated with Pediatric Cardiology in USA:

Hospitals Associated with Pediatric Cardiology Worldwide:

Industries Associated with Pediatric Cardiology in Chicago:

Industries Associated with Pediatric Cardiology in USA:

Industries Associated with Pediatric Cardiology Worldwide:

Estimated market growth of Pediatric Cardiology:

The North American interventional cardiology devices market is expected to reach $5,947.5 million by 2018. Global Interventional Cardiology market is estimated to reach US $22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US $20.6 billion by 2016, growing 9.2% for the analysis period 2012-2018 respectively.

The report studies the global pediatric interventional cardiology market over the forecast period of 2013 to 2018. This market is valued at an estimated $894.7 million in 2013 and is poised to grow at a CAGR of 9.0% from 2013 to 2018.

Products Manufactured by the industry related Pediatric Cardiology Research and its Market Value:

For children with in-hospital pVT/VF, lidocaine use was independently associated with improved ROSC and 24-h survival. Amiodarone use was not associated with superior rates of ROSC, survival at 24h. Neither drug was associated with survival to hospital discharge. These are some more popularly used drug for cardiac diseases.

Fund Allotment (in Million Dollars) to Pediatric Cardiology Research:

The Childrens Heart Foundation (CHF) represents approximately two million American children and adults as well as 65 million children and adults worldwide who are afflicted with Congenital Heart Disease (CHD). Each year over one million babies around the world, including 40,000 in the United States, are born with a congenital heart defect (March of Dimes). CHD is the leading cause of death from birth defects. Although mortality rates have been improving, CHD contributed to 5810 deaths in the US in 2004 (NCHS). Clearly, advocacy for more research is vitally needed.

These are the find allotted by NIH in various years to cardiology research department. The Childrens Heart Foundation has over $6.3 million to 58 basic science, translational and clinical CHD research projects at leading research centers across the US and Canada. The Israeli Ministry for Regional Cooperation has committed NIS 1 million (some $260,000) to supporting life-saving heart surgery for 100 Iraqi, Palestinian and Jordanian children in the coming year.

Statistics of Physicians, Researchers and Academicians working on Pediatric Cardiology Research:

The main part of the world associated with Pediatric Cardiology field are Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students and Writers of Pediatric Cardiology Department as well as Founders and Employees of the related companies, Associations members, related organizations, laboratories members etc.

Pediatric Cardiology 2016

The 2nd Global Congress on Pediatric Cardiology& Healthcare organized by Conference series LLC was successfully held atHotel Embassy SuitesinLas Vegas, USAduringSeptember 22-24, 2016. The conference was organized around the theme Evolution of modern theories and therapies to save the children heart & Lungs. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals as well as from eminent Scientists, Talented Researchers and Young Student Community.

Researchers and students who attended from different parts of the world has made the conference one of the most successful and productive events in 2015 from Conferenceseries LLC. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations. Pediatric Cardiology 2016 Organizing Committee would like to thank the Moderator of the conference,Dr. Randy Richardson, Creighton University School of Medicine, USA and Dr. Amir A Sepehri, CAPIS, Belgium who contributed a lot for the smooth functioning of this event. The conference was initiated with a warm Welcome Note and the Book Launch by Honorable Guests and the Keynote Forum.The conference proceedings were carried out through various scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

Impact of pre-procedural simulation and planning using 3-D resin (solid) and photopolymer (flexible) models on interventional cardiac procedures, byDr. Randy Richardson, Creighton University School of Medicine, USA.

Irreversible SD in a pediatric PM patient despite immediate CPR: A medico-legal case, byDr. Guy Hugues Fontaine,Universit Pierre et Marie Curie, France.

The genetic aspect of human heart development in aspect of prenatal diagnosis byDr. Krzysztof Piotrowski, Pomeranian Medical University, Poland.

Correction of congenital heart disease in the current era: From the operative room to the catheterization lab, byDr. Howard Weber, Penn State Hershey Childrens Hospital, USA.

Clinical course and prognosis of hypertrophic cardiomyopathy in Egyptian children, byDr. Sonia El Saied Cairo University, Egypt.

"Heart Sound Auscultation, Past, Present and Future" by Dr. Amir A Sepehri, CAPIS, Belgium.

Conferenceseries LLC extends its warm gratitude to all the Honorable Guests of Pediatric Cardiology 2016:

Originally posted here:
Worlds Leading Pediatric Cardiology Congress | American ...

There is something very unique going on at the Prairie Heart Institute in Springfield, Illinois.

Prairie Heart Institute is participating in an investigational clinical study called ALLSTAR, using donor heart cells that may help patients who have suffered a heart attack regenerate the dead heart muscle that is often the result of such an event. Heart muscle dies even if the patient survives a heart attack. This results in a less efficient heart and reduces blood flow through the body.

The Prairie Heart Institute at St. John's hospital in Springfield, Illinois is one of approximately thirty sites testing the investigational procedure in the ALLSTAR trial sponsored by Capricor, Inc., a Los Angeles biotechnology company. The procedure infuses healthy cardiac cells from a donor heart that are meant to boost the damaged heart's natural ability to repair itself. If it works, functional heart muscle should grow replacing the dead heart muscle thereby potentially improving the strength and efficiency of the beating heart.

The trial has successfully completed Phase I, which mainly evaluated safety. Capricor has received permission to begin Phase II, and ALLSTAR will continue to examine safety along with efficacy in approximately 300 patients who will receive either the investigational procedure or a placebo. More information can be found at clinicaltrials.gov under the identifier NCT01458405.

"The previous study used autologous cells, taken from the treated patient itself. However, using donor cells may be preferable over autologous for practical reasons," said Dr. Frank Aguirre, the cardiologist heading up the clinical study at Prairie Heart Institute. "Donor cells, called allogeneic cells, can be banked in advance and used when needed, said Aguirre, similar to a blood transfusion. Theyre also less expensive because of economies of scale"

Research by Capricor founder Dr. Eduardo Marbn discovered the heart contained cells with regenerative capacity.

"No one knew these existed, Aguirre said. Everyone thought the heart was an organ that couldnt repair itself. But it turns out that may be wrong, and that there are early progenitor types cells in the heart that may be effective."

When injected into hearts, unlike embryonic stem cells which are expected to engraft into the target organ, these progenitor cells are expected to remain transiently in the heart but induce growth of new heart tissue which continues after they are no longer present.

We invite health consumers to participate in the AllStar trial please click here to see if you qualify.

If you believe you may qualify for the ALLSTAR trial, please call 217-492-9105.

The Prairie Heart Institute of Illinois (PHII) is a community-based network of hospitals that offer cardiovascular programs staffed by the nationally recognized Prairie Cardiovascular Consultants, the largest group of cardiologists in the tri-state region. Because of the Prairie Education and Research Consortium (PERC), network hospitals also have access to drugs and treatment not widely available. The network hospitals of PHII offer the highest level of cardiovascular care possible in their communities. When more specialized care is needed, it is available in Springfield, Belleville or Carbondale.

PERC was founded in 1983 to facilitate cardiovascular and vascular clinical research, thereby integrating state of the art medical science and bedside patient care. PERC has been instrumental in fostering collaborative efforts between physicians, medical industry, and the international clinical research community, as all parties work together to study the introduction of new pharmaceuticals, cardiovascular techniques and medical devices. Over the past two decades, the evolution of this important cooperative effort has been reflected in the growth of PERC to its present size.

See the original post here:
Prairie Heart

About R3 and Illinois Pain Network

R3 Stem Cell offers regenerative treatment options throughout the US that bring patients hope along with relief. Hope that surgery may be avoided, and regeneration and repair of damaged tissue without surgery. The person may then be able to participate in desired activities like swimming, biking, hiking, football, golf, playing with your kids again and being Pain Free!

R3 Stem Cell partners with the top pain and orthopedic practices nationwide to offer stem cell and PRP therapy to those desiring state-of-the-art treatment by compassionate, Board Certified providers. The Illinois Pain Network offers the top pain management providers in Chicago, Rockford, Joliet, Peoria, Naperville and surrouding areas. R3 is proud to work with the professionals in the Network, helping patients to receive regenerative therapies with the latest effective technology available.

Conventional pain treatments have been very good at reducing pain by masking discomfort in a band aid fashion with oral or injected medications like steroids, narcotics, or NSAIDs. These therapies unfortunately do not fix the underlying problem.

Fixing Tissue Injury

So how is the condition actually repaired, whether its shoulder/knee/hip/ankle arthritis, back or neck pain, golfers or tennis elbow, rotator cuff tendonitis or a ligament injury?

Regenerative Medicine with the Illinois Pain Network has the potential to restore anatomy with stem cells, growth factors and platelets to facilitate a healing response in ones own body.

Stem Cells are like a blank slate and may differentiate into any number of cell types for tissue regeneration. This is in large part dependent on the environment in which they are placed.

Illinois Stem Cell Procedures

Stem cell injection treatments include:

These are all minimally invasive, same day, low risk, outpatient procedures. The treatments may be partially covered by insurance.

Initial studies are showing these stem cell therapies to offer substantial promise in healing injury while reducing pain. For example, most professional sports leagues have approved of PRP therapy along with the World Anti-Doping Association.

Pro athletes who have received regenerative medicine treatment include the likes of Rafael Nadal, Dwight Howard, Tiger Woods, Kobe Bryant, Bartolo Colon and many more.

All of the treatments with the Illinois Pain Network are performed by Board Certified physicians.

Dr. Mark Farag is a double-board certified and fellowship-trained anesthesiologist and interventional pain management specialist. He attended the University of Illinois at Chicago for his anesthesiology residency and interventional pain management fellowship.

He is compassionate, intelligent, and always dedicated to giving his patients the highest quality of care. He focuses on using a multi-modal approach (procedures, medications, physical therapy, and other therapies) to treat the pain at its source, and help his patients resume a fulfilling personal, professional, and social life.

Dr. Rakic is double-board certified in both anesthesiology and pain management. He was a professor at the University of Illinois, specializing in in general anesthesia, regional anesthesia and pain management. He is interested in spine and orthopedic pain, cancer pain, as well as neuropathic pain conditions.

He brings a University level of care to patients and loves to offer regenerative medicine procedures including PRP and stem cell therapy to help provide relief. Most patients are able to avoid surgery and increase their functional abilities. Dr. Rakic also speaks Spanish and Serbian.

Dr. Pontinen is a double-board certified anesthesiologist and interventional pain medicine specialist. He has also undergone formal training as a resident in general surgery, which allows him to perform the most innovative procedures in pain medicine safely and skillfully.

He is a compassionate physician who works daily to help his patients regain their lives and get back to doing the activities they love. He is passionate about treating the most complex pain cases in a comprehensive, integrative and holistic approach, combining multiple treatment modalities with the most innovative, minimally invasive procedures.

This includes cutting edge regenerative medicine procedures for arthritis, tendonitis, sports injuries, migraines, chronic wounds and more.

Dr. Saldanha is double-board certified in both anesthesiology and pain medicine. Dr. Saldanha is a compassionate physician who is driven to provide healthcare to patients, regardless of background.

His expertise spans both medical management and interventional procedures, which includes PRP and stem cell therapy. Patients with all types of bone, joint and soft tissue conditions are treated with the regenerative medicine procedures to help repair and regenerate injury!

If you would like to receive stem cell therapy partially covered by insurance, CONTACT US or call (888) 885-8675 today!

Save

Save

Save

Here is the original post:
Regenerative Stem Cell Injections | Stem Cell Therapy Illinois

Unless you are the self-proclaimed science nerd of your friend and family circle, most people dont quite understand stem cell research and the ethical issues surrounding it.

If you try to learn more from Google, you will likely be bombarded by medical lingo until you feel immersed in a foreign language.

Have no fear, heres a few things you need to know about stem cell research to impress your science nerd friends.

1 What exactly is embryonic stem cell research?

Human embryonic stem cell research usually begins when scientists manufacture conception within a lab. Once conception has been manufactured, the tiny human is allowed to grow for about 3-5 days. Then, the developing human is usually killed in order to harvest the stem cells for research.

2 Why is embryonic stem cell research unethical?

At conception this tiny humans hair color, eye color, and sex have already been determined. The tiny humans DNA is completely unique from the mother and father and will never again be repeated in the history of the human race. To conduct embryonic stem cell research, scientists usually stop that rapidly growing tiny human from developing which otherwise left alone would become a fully formed human being. Remember, you and I started out this small too!

3 Is embryonic stem cell research successful?

Not exactly. Not only is it very controversial, it has been found highly ineffective as well. Adult stem cell research has been found to be significantly more successful.

4 So Adult Stem Cell research is ethical, right?

Not so fast. Most of adult stem cell research is ethical and shows very encouraging results to cure neurological and other diseases. However the word adult in stem cell research is used to describe the age of the cell not the age of the person its is taken from. Therefore, adult stem cells can also be used to describe cells taken from an aborted child.

5 Where I can find more information?

You can find more information at http://www.stemcellresearch.org. You can also find additional information at Wisconsin Right to Life.

See more here:

Stem Cell Research | Illinois Right to Life